SPOTLIGHT -
Yes. The risk/benefit equation still favors oophorectomy to save lives.
Placebo pills found to significantly reduce premenstrual syndrome symptoms
A new study found that open-label placebos can effectively reduce the intensity and interference of premenstrual syndrome symptoms, even when patients know they are taking a placebo.
Read More
Pap Talk S4E15: MIRA surgical system for hysterectomy with Jean Dubuisson, MD, PhD
In this episode of Pap Talk, Jean Dubuisson, MD, PhD, discusses the first successful hysterectomy performed using the MIRA surgical system.
Listen
Kynurenine pathway may explain higher depression odds in adolescent girls
A new study suggests that sex-based differences in the kynurenine pathway may contribute to depression risk in adolescents, offering insights for personalized treatment approaches.
How Individually Identifying More HPV Types Enables Better Patient Management and More Precise Care
AHN is transforming high-risk pregnancy care: Diabetes management, genetic testing and more
FDA approves gepotidacin for uncomplicated UTI treatment
The approval marks a vital step toward care for urinary tract infections, helping to reduce recurrence and improve patients’ quality of life.